PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹2,158 Cr | ₹2,350 Cr | ₹2,134 Cr | ₹1,799 Cr | ₹1,785 Cr |
What is the latest Sundry Debtors ratio of PIRAMAL PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹2,158 Cr |
| Mar2025 | ₹2,350 Cr |
| Mar2024 | ₹2,134 Cr |
| Mar2023 | ₹1,799 Cr |
| Mar2022 | ₹1,785 Cr |
How is Sundry Debtors of PIRAMAL PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,158 Cr | -8.17 | |
| Mar2025 | ₹2,350 Cr | 10.08 | |
| Mar2024 | ₹2,134 Cr | 18.62 | |
| Mar2023 | ₹1,799 Cr | 0.79 | |
| Mar2022 | ₹1,785 Cr | - | |
Compare Sundry Debtors of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,865.1 Cr | -0.1% | 2.7% | -14.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -0.1% |
2.7% |
-14.6% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses